Regeneron Pharmaceuticals (REGN) Options Chain & Prices $675.50 -1.19 (-0.18%) As of 11:27 AM Eastern This is a fair market value price provided by Massive. Learn more. Add Compare Share Share Options Chain Stock AnalysisAnalyst ForecastsChartCompetitorsDividendEarningsFDA EventsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestTrendsBuy This Stock REGN Put and Call Options List 6/16/2028 1/21/2028 6/17/2027 3/19/2027 2/19/2027 1/15/2027 12/18/2026 11/20/2026 10/16/2026 9/18/2026 8/28/2026 8/21/2026 8/14/2026 8/7/2026 7/31/2026 7/24/2026 Options Date Put and Call Options Put Options Call Options Options Type All In The Money Out of The Money Moneyness With Volume Without Volume All Volume Strike Price Min Strike Price Max Export ExpiresStrike PriceClose PricePut/CallVolumeVolume AskVolume BidOpen InterestImplied VolatilityDeltaTrades7/24/2026$590.00$0.385Put2 - 121(-1)50.16% (-1.43%)-0.02224727/24/2026$600.00$77.735Call1 - - 59(+0)47.19% (-1.39%)0.96924917/24/2026$610.00$67.932Call2 - - 23(+0)44.24% (-1.36%)0.95758217/24/2026$620.00$58.217Call2 - - 25(+0)41.32% (-1.34%)0.9405627/24/2026$630.00$1.398Put5 - - 18(+6)38.44% (-1.35%)-0.0844627/24/2026$640.00$2.037Put5 - - 47(+0)35.63% (-1.33%)-0.1225127/24/2026$640.00$39.284Call1 - - 22(+0)35.63% (-1.31%)0.87738817/24/2026$650.00$3.053Put8 - 320(+5)32.96% (-1.32%)-0.18007857/24/2026$660.00$4.706Put1 - - 3(+0)30.53% (-1.28%)-0.26588517/24/2026$660.00$21.956Call1 - - 10(+0)30.53% (-1.28%)0.7345911 Get the Latest News and Ratings for REGN and Related StocksEnter your email address below to receive the latest news and analysts' ratings for Regeneron Pharmaceuticals and its competitors with MarketBeat's FREE daily newsletter. 7/24/2026$662.50$5.265Put3 - - 0(+0)29.98% (-1.28%)-0.29277417/24/2026$662.50$20.014Call2 - - 10(+0)29.98% (-1.28%)0.70787217/24/2026$665.00$5.897Put1 - - 0(+0)29.47% (-1.27%)-0.32189717/24/2026$667.50$6.613Put3 - - 0(+0)28.99% (-1.26%)-0.35335517/24/2026$670.00$7.419Put1 - - 2(+0)28.55% (-1.24%)-0.38688517/24/2026$670.00$14.666Call54 - 85(+0)28.55% (-1.24%)0.61423527/24/2026$675.00$9.339Put22 - 4(+2)27.82% (-1.21%)-0.45944817/24/2026$677.50$10.468Put11 - 1(+1)27.54% (-1.19%)-0.49768117/24/2026$680.00$11.715Put1 - - 6(+1)27.32% (-1.16%)-0.53645917/24/2026$680.00$8.950Call2 - - 25(+0)27.32% (-1.16%)0.46558327/24/2026$685.00$6.795Call4 - - 1(+1)27.06% (-1.11%)0.38921227/24/2026$690.00$5.102Call11 - - 9(+3)27.05% (-1.04%)0.31777147/24/2026$700.00$2.862Call42 - 7(+0)27.71% (-0.91%)0.20220447/24/2026$710.00$1.652Call5140(+0)29.02% (-0.80%)0.12608437/24/2026$715.00$1.276Call21 - 1(+0)29.82% (-0.76%)0.09991227/24/2026$720.00$0.999Call4 - - 0(+0)30.69% (-0.73%)0.07961317/24/2026$730.00$0.633Call2 - 24(+0)32.55% (-0.67%)0.0516212End-of-day options data provided by Trade Alert and Intrinio. Related Companies and Tools Related Companies AMGN Options Chain GILD Options Chain MRNA Options Chain NTLA Options Chain VIR Options Chain VRTX Options Chain ABBV Options Chain LLY Options Chain MRK Options Chain PFE Options Chain Options Chain Tools Short Interest TrackerShort Interest IncreasesShort Interest DecreasesUnusual Call VolumeUnusual Put Volume This page (NASDAQ:REGN) was last updated on 7/20/2026 by MarketBeat.com Staff. From Our PartnersMan who Predicted Trump 2016 Win: “Prepare for Mid-Term Meltdown”In 2016, major election models gave Hillary Clinton a 99% chance of winning - but former CIA and Pentagon advi...Paradigm Press | SponsoredNVIDIA offered $40B. The answer was no.Apple, NVIDIA, Google, Amazon, and Samsung all pay one company billions in royalties every year. NVIDIA tried ...Behind the Markets | SponsoredTrump’s $250 Bill – See ImmediatelyFormer Goldman Sachs VP Dr. David Eifrig is warning that July 28 could trigger the biggest wealth reset in mod...Stansberry Research | SponsoredThe end may be near for these iconic stocksMarc Chaikin, founder of Chaikin Analytics, says two forces - AI disruption and fracturing global trade - are ...Chaikin Analytics | SponsoredThe gold strategy buried in Trump's plans that insiders are already watchingNancy Pelosi's portfolio gained 71 percent in 2024 while the S&P 500 returned just 28 percent. In 2023, she ea...American Alternative | SponsoredSMX: From Under-the-Radar to Must-Watch!SMX (Security Matters) PLC is building Digital Material Passport technology that embeds molecular-level marker...Smallcaps Daily | SponsoredMy next big call (under $1)17,556% on KDA. Here's what I'm buying now. It's a coin under $1.00 that most investors have never heard of...Crypto 101 Media | SponsoredNew Dollar Plan Could Drain Your Account (Silently)Washington's so-called 'Mar-a-Lago Accord' aims to deliberately weaken the U.S. dollar to boost exports and br...Priority Gold | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Regeneron Pharmaceuticals, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Regeneron Pharmaceuticals With A Colleague Link copied to clipboard. Unlock superior investment research and tools. Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools and reports. Get MarketBeat All Access MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In Email Me a Login Link or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Free REGN Stock Alerts